Ashwagandha and Sleep: What the Research Actually Shows

Sleep is written into the plant's name. The botanical name for ashwagandha is Withania somnifera, and somnifera is Latin for sleep bringing. The claim was made long before anyone owned a stopwatch, let alone a sleep laboratory.

So the interesting question is not whether the tradition connected this root to sleep. It plainly did. The question is what happens when you take that old claim into a modern trial and actually measure it.

What a Sleep Study Actually Measures

This matters more than it sounds, because sleep is measured in two quite different ways, and they do not always agree.

The first is subjective. You ask people how they slept, usually with a validated questionnaire such as the Pittsburgh Sleep Quality Index. The second is objective. You strap a device to the wrist, or run a full sleep study, and record what the body actually did. From that you get numbers with precise meanings. Sleep onset latency, how long it takes to fall asleep. Total sleep time. Sleep efficiency, the share of time in bed actually spent asleep. Wake after sleep onset, how much you are awake once you have dropped off.

A supplement can move some of these and not others. Keeping the distinction in view is most of what separates a careful reading from a hopeful one.

A Trial Worth Looking At

Take a study by Langade and colleagues, published in Cureus in 2019. It is small, but it is specific, and specificity is where the truth usually hides.

Sixty patients diagnosed with insomnia and anxiety were randomised, two to one, to receive either 300mg of a full-spectrum ashwagandha root extract twice daily or an identical starch placebo, for ten weeks. Sleep was tracked with actigraphy, a wrist device, rather than by memory alone.

The results favoured the extract. Sleep efficiency rose from around 76 per cent to 83 per cent in the treatment group, against a smaller rise on placebo. Time to fall asleep shortened, and sleep quality improved on the rating scale, at p=0.002. The effect was real, measured on the wrist rather than reported from the pillow.

It is also one clinic, sixty people, ten weeks, one extract. A good study, not a last word. The authors say as much, calling for larger trials.

The plant did not need a trial to earn its name. It needs one to earn a claim. Those are different things, and the gap between them is where the honest reading lives.

Does It Hold Across More Studies?

On sleep, cautiously, yes.

A systematic review and meta-analysis published in PLOS One in 2021 pooled five randomised controlled trials covering 400 adults. Across them, ashwagandha produced a small but statistically significant improvement in overall sleep, a standardised mean difference of 0.59, with a confidence interval that did not cross zero. Small but real, in the language of the field.

The more useful finding is buried in the subgroups. The effect was more prominent in three specific circumstances: in adults actually diagnosed with insomnia, at doses of 600mg a day or more, and over treatment lasting eight weeks or longer. The review also noted improvements in morning alertness and anxiety, and, tellingly, no significant effect on general quality of life. No serious side effects were reported, though the authors were careful to add that long-term safety data is thin.

Read plainly, that is a modest average effect that becomes meaningful mainly when the person has a genuine sleep problem, takes enough, and gives it time.

Where the Picture Gets Complicated

Here is the part the label leaves out.

A second systematic review and meta-analysis, published in Human Psychopharmacology in 2024, pooled five trials covering 254 people with anxiety or insomnia. It found that ashwagandha significantly improved several sleep measures, including how quickly people fell asleep, total sleep time, sleep efficiency and the overall quality index. But it found no significant effect on wake after sleep onset, the amount of time spent awake in the night, or on total time in bed.

So the picture is not uniform. Some parts of sleep moved, and at least one did not. The same analysis reported very high statistical heterogeneity between the studies, which is a technical way of saying the trials differed from one another enough that pooling them is an uneasy business. The authors reached the same conclusion everyone reaches here. Promising, and in need of larger studies.

None of this cancels the earlier finding. It refines it. The effect looks most convincing on getting to sleep and on the efficiency of the night overall, and least convincing on staying asleep once you are there.

Dose and Duration Are Not Details

The thread running through all of it is the same one that runs through the stress research. The trials that found effects were not short and were not low dose.

The clearest sleep benefit in the 2021 review clustered at 600mg a day or more, sustained for eight weeks or longer. The Langade trial ran for ten. Nothing in this literature describes a result on the first night. A botanical that needs two months to show itself is not a sedative, and should not be read as one.

The Caveat That Applies to All of It

One structural problem sits underneath every study above. They did not all test the same thing.

The trials used different branded, standardised extracts, made by different methods, with different withanolide content, sometimes from root and sometimes including leaf. Withanolides are the compounds researchers track as the closest thing the plant has to an active dose, and the amount varies from one preparation to the next. A result obtained with one extract at one dose does not automatically transfer to a different extract at a different dose. It is the single most important thing to understand about this ingredient, and the number most often missing from a label.

Safety, and the UK Review Underway

An honest write-up of this ingredient does not stop at the benefits. It says plainly who should be careful.

In trials, ashwagandha is generally well tolerated over a few months, with side effects that are usually mild, such as stomach upset, loose stools, nausea and drowsiness. Evidence over longer periods is lacking. There are also documented case reports of more serious harm, including acute liver injury, and some research points to effects on thyroid function. It may interact with medication for the thyroid, for diabetes, for blood pressure, and with sedatives and immunosuppressants. The drowsiness point is worth holding in mind precisely because sleep is the reason a person might reach for it.

Several countries have acted on these concerns. Denmark restricted its use in food supplements. France, through its food safety agency ANSES, advised against use in certain groups including pregnant and breastfeeding women and people with endocrine disorders.

In the United Kingdom, the Food Standards Agency has referred ashwagandha to the Committee on Toxicity for a formal safety assessment. The FSA ran a call for evidence that opened on 8 July 2024 and closed on 1 September 2024, and it published a summary of the responses on 25 June 2026. The Committee has been working through a draft statement during 2026. As things stand, no safe consumption level has been established in the UK and no final conclusion has been published. Ashwagandha is not banned here and remains legally available, but anyone taking it should know that a review is genuinely in progress.

If you are pregnant or breastfeeding, under eighteen, have a thyroid or liver condition, or take any prescribed medication, this is a conversation to have with your doctor or pharmacist rather than a decision to make from a blog post.

The Honest Summary

The oldest claim about this plant, the one baked into its name, is also one of the better supported. Across several trials and two independent meta-analyses, ashwagandha is associated with modestly better sleep, and the benefit is clearest for the people who need it most, at a real dose, over a real stretch of time.

What it is not is a switch. The average effect is small, the studies disagree on which parts of the night improve, the preparations differ from one another, and a UK regulator is examining the safety of the ingredient as this is written. A plant named for sleep, three thousand years ago, turns out to have been onto something. It also turns out to be more modest, and more particular, than the name promised.

References

1. Langade, D. et al. Efficacy and safety of ashwagandha (Withania somnifera) root extract in insomnia and anxiety, a double-blind, randomized, placebo-controlled study. Cureus, 11(9), e5797, 2019. DOI
2. Cheah, K.L., Norhayati, M.N., Husniati Yaacob, L. and Abdul Rahman, R. Effect of ashwagandha (Withania somnifera) extract on sleep, a systematic review and meta-analysis. PLOS One, 16(9), e0257843, 2021. DOI
3. Fatima, K. et al. Safety and efficacy of Withania somnifera for anxiety and insomnia, systematic review and meta-analysis. Human Psychopharmacology, 39(6), e2911, 2024. DOI
4. National Institutes of Health, Office of Dietary Supplements. Ashwagandha, is it helpful for stress, anxiety, or sleep? Health professional fact sheet, updated 2025. Link
5. Food Standards Agency. Summary of responses to call for evidence on ashwagandha, published 25 June 2026. Link

This article is for informational purposes only and is not intended as medical advice, nor as a description of any particular product. It discusses the botanical Withania somnifera and published third-party research. Food supplements are not a substitute for a varied, balanced diet and a healthy lifestyle. Individual responses vary. Ashwagandha is not suitable for everyone, including during pregnancy and breastfeeding, and it may interact with prescribed medication. Always consult a qualified healthcare professional before starting or changing any supplement routine, particularly if you are taking medication or have a diagnosed health condition.